We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$99.1B
AUM Growth
+$7.92B
Cap. Flow
+$3.27B
Cap. Flow %
3.3%
Top 10 Hldgs %
23.39%
Holding
4,186
New
432
Increased
2,037
Reduced
1,399
Closed
199

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$1.36B
2
MTUM icon
iShares MSCI USA Momentum Factor ETF
MTUM
+$277M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$237M
4
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$86.7M
5
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$80.9M

Top Sells

Rank Stock Value
1
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$671M
2
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$414M
3
ISTB icon
iShares Core 1-5 Year USD Bond ETF
ISTB
+$130M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$72.5M
5
SUB icon
iShares Short-Term National Muni Bond ETF
SUB
+$65.1M

Sector Composition

Rank Sector Weight
1 Technology 14%
2 Financials 8.86%
3 Healthcare 8.09%
4 Industrials 6.83%
5 Consumer Discretionary 6.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADT icon
3951
CALL
ADT
ADT
$5.5B
– –
-12,000
Closed -$11K
AG icon
3952
PUT
First Majestic Silver
AG
$9.22B
– –
-82,500
Closed -$33K
AIRG icon
3953
Airgain
AIRG
$71.1M
– –
-14,559
Closed -$259K
ALLO icon
3954
Allogene Therapeutics
ALLO
$742M
– –
-15,495
Closed -$391K
AMPH icon
3955
Amphastar Pharmaceuticals
AMPH
$864M
– –
-13,666
Closed -$275K
AMZN icon
3956
CALL
Amazon
AMZN
$2.93T
– –
-12,000
Closed -$674K
ANIK icon
3957
Anika Therapeutics
ANIK
$282M
– –
-6,154
Closed -$279K
AOA icon
3958
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.27B
– –
-6,697
Closed -$430K
ARRY icon
3959
Array Technologies
ARRY
$821M
– –
-5,605
Closed -$242K
ASAN icon
3960
Asana
ASAN
$2.16B
– –
-36,166
Closed -$1.07M
ASB icon
3961
Associated Banc-Corp
ASB
$5.98B
– –
-70,165
Closed -$1.2M
AUPH icon
3962
Aurinia Pharmaceuticals
AUPH
$2.05B
– –
-10,750
Closed -$149K
BA icon
3963
PUT
Boeing
BA
$185B
– –
-3,300
Closed -$385K
BDTX icon
3964
Black Diamond Therapeutics
BDTX
$115M
– –
-7,467
Closed -$239K
BGFV
3965
DELISTED
Big 5 Sporting Goods
BGFV
– –
-12,975
Closed -$132K
BLFS icon
3966
BioLife Solutions
BLFS
$1.71B
– –
-5,927
Closed -$236K
BLUE
3967
DELISTED
bluebird bio
BLUE
– –
-1,460
Closed -$818K
BRT
3968
BRT Apartments
BRT
$266M
– –
-13,627
Closed -$207K
BVN icon
3969
Compañía de Minas Buenaventura
BVN
$8.79B
– –
-19,672
Closed -$240K
CDLX icon
3970
Cardlytics
CDLX
$21.8M
– –
-143
Closed -$203K
CHCT
3971
Community Healthcare Trust
CHCT
$434M
– –
-4,403
Closed -$207K
CHEF icon
3972
CALL
Chefs' Warehouse
CHEF
$4.49B
– –
-65,800
Closed -$467K
CORT icon
3973
Corcept Therapeutics
CORT
$12.2B
– –
-70,264
Closed -$1.84M
COTY icon
3974
CALL
Coty
COTY
$2.49B
– –
-13,000
Closed -$3K
CPRX
3975
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-11,726
Closed -$39K
157 158
159
160 161

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Raymond James & Associates held 4,186 positions worth $99.1B, up 8.7% from $91.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates deployed $3.27B of net new capital in Q1 2021, opening 432 new positions and adding to 2,037 existing holdings. Its largest new stake was BlackRock Technology and Private Equity Term Trust: 1,676,875 shares worth $34M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard High Dividend Yield ETF, an estimated $671M trimmed.

  • Raymond James & Associates's largest Q1 2021 buy was BlackRock Technology and Private Equity Term Trust: 1,676,875 shares worth $34M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2021, an estimated $1.36B increase.
  • Raymond James & Associates's biggest Q1 2021 reduction was Vanguard High Dividend Yield ETF, cutting an estimated $671M.
  • Raymond James & Associates fully exited Sensient Technologies in Q1 2021, selling an estimated $15.6M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $99.1B portfolio in Q1 2021.
  • Raymond James & Associates opened 432 new positions and closed 199 in Q1 2021.
  • Raymond James & Associates's portfolio value rose 8.7% quarter-over-quarter to $99.1B.

Based on Raymond James & Associates's 13F filing for Q1 2021, filed 14 May 2021.